Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Meloxicam Capsules vs Tablets in Healthy Volunteers
NCT02183181Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of meloxicam in osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS), sponsored by Boehringer Ingelheim. Started Nov 2008; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02183181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183181.